» Articles » PMID: 26877754

Transdiagnostic Treatment of Co-occurrence of Anxiety and Depressive Disorders Based on Repetitive Negative Thinking: A Case Series

Overview
Specialty Psychiatry
Date 2016 Feb 16
PMID 26877754
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The transdiagnostic cognitive behavioral treatments for treating the coexistence of anxiety and mood disorders received useful empirical supports in the recent years. However, these treatments still have moderate efficacy. Following the improvements and developments in transdiagnostic protocols and considering the importance of repetitive negative thinking as a core transdiagnostic factor in emotional disorders, this study examined a new form of transdiagnostic treatment based on Repetitive Negative Thinking (TTRNT) of co-occurrence of anxiety and depressive disorders.

Methods: Treatment efficacy was assessed using single case series with multiple baselines. Three patients meeting the criteria for co-occurrence of anxiety and depressive disorders were selected using the Anxiety Disorders Interview Schedule for DSM-IV. The patients were treated individually for 12 weekly sessions. Participants completed the standardized outcome measures during the baseline, treatment and one-month follow-up.

Results: At post-treatment, all participants showed significant clinical changes on a range of standardized outcome measures, and these gains were largely maintained through the one-month follow-up both in the principle and co-principal diagnosis.

Conclusions: Although the results of this preliminary investigation indicated that TTRNT could be a time effective and efficient treatment for individuals with co-occurrence of anxiety and depressive disorders, further controlled clinical trials are necessary to examine this new treatment approach.

Citing Articles

Psychometric properties of the Spanish version of the hospital anxiety and depression scale in cancer patients.

Vilela-Estrada A, Villarreal-Zegarra D, Copez-Lonzoy A, Esenarro-Valencia L, Sanchez-Ramirez J, Lamas-Delgado F Front Psychol. 2025; 15:1497946.

PMID: 39944710 PMC: 11816369. DOI: 10.3389/fpsyg.2024.1497946.


Intolerance of uncertainty on distress and impairment: The mediating role of repetitive negative thinking.

Kelso K, Gros D J Psychopathol Behav Assess. 2024; 2024.

PMID: 39246301 PMC: 11378962. DOI: 10.1007/s10862-024-10157-w.


Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders.

Steele S, Farchione T, Cassiello-Robbins C, Ametaj A, Sbi S, Sauer-Zavala S J Psychiatr Res. 2018; 104:211-216.

PMID: 30103069 PMC: 6219859. DOI: 10.1016/j.jpsychires.2018.08.005.

References
1.
McEvoy P, Nathan P . Effectiveness of cognitive behavior therapy for diagnostically heterogeneous groups: a benchmarking study. J Consult Clin Psychol. 2007; 75(2):344-50. DOI: 10.1037/0022-006X.75.2.344. View

2.
Brown T, Campbell L, Lehman C, Grisham J, Mancill R . Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001; 110(4):585-99. DOI: 10.1037//0021-843x.110.4.585. View

3.
Spasojevic J, Alloy L . Rumination as a common mechanism relating depressive risk factors to depression. Emotion. 2003; 1(1):25-37. DOI: 10.1037/1528-3542.1.1.25. View

4.
Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N . Psychometric properties of a Persian-language version of the Beck Depression Inventory--Second edition: BDI-II-PERSIAN. Depress Anxiety. 2005; 21(4):185-92. DOI: 10.1002/da.20070. View

5.
Brown T, Barlow D . A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess. 2009; 21(3):256-71. PMC: 2845450. DOI: 10.1037/a0016608. View